Albenberg L, et al. – Via analysis of results from the Food and Crohn’s Disease Exacerbation Study (FACES) trial, researchers ascertained if reduced red and processed meat consumption decreases the risk of symptomatic Crohn’s disease (CD) relapse. From November 2013 to June 2015, adults with CD were recruited from Inflammatory Bowel Disease (IBD) Partners, an internet-based cohort of IBD patients, in the FACES trial. A total of 118 individuals were assigned to a high-meat group and 96 individuals were randomly allocated to a low-meat group. Those in the high-meat group reported consumption of two or more servings of red or processed meat during 98.5% of observed weeks vs 18.8% of weeks for those in the low-meat group during the trial. In 62% of participants in the high-meat group and 42% of participants in the low-meat group, any and moderate-to-severe relapse occurred. According to findings, level of red and processed meat intake was not linked to time to symptomatic relapse among patients with CD in remission.